Skip to main content
. Author manuscript; available in PMC: 2019 Feb 22.
Published in final edited form as: J Nucl Med. 2012 Nov 8;53(12):1933–1942. doi: 10.2967/jnumed.112.105056

FIGURE 6.

FIGURE 6.

Combination therapy with GLV-1h153 and 131I mediates enhanced tumor kill. Although groups of mice treated with PBS, GLV-1h153 alone, and 131I alone continued to experience rapid tumor growth in radiovirotherapeutic experiment, mice treated with GLV-1h153 plus 131I experienced retardation and even regression of tumor volume. Statistical analysis was performed using 1-way ANOVA. **P, 0.01 for comparison of untreated control, GLV-1h153, or 131I groups alone with GLV-1h153 plus 131I groups. *P, 0.05 for comparison of untreated control, GLV-1h153, or 131I groups alone with GLV-1h153 plus 131I groups.